Today

Agents

Chat

Arena

Discover

More

App

Design Therapeutics Q2 Basic EPS USD -0.32 - DSGN News | Rallies

Design Therapeutics Q2 Basic EPS USD -0.32

DSGN•2026-08-03

Q2 results

Aug. 3 (Reuters) - Design Therapeutics Q2 operating expenses were USD 22.177 million.

Q2 net income: USD -20.165 million vs. IBES estimate of USD -21.3 million
Q2 operating income: USD -22.177 million

Related News

BUZZ-Lantheus climbs on Curium's up to $8 bln buyout offer

LNTH•2026-08-03

First Busey names Michael Peluso general counsel, succeeding John Powers

BUSE•2026-08-03

Sleep Number closes asset sale to Sleep Country Canada unit for USD 529.5 million

•

2026-08-03

Marvell showcases AI memory, storage infrastructure portfolio at FMS 2026

MRVL•2026-08-03

Tyson Foods cuts profit forecast as tight US cattle supplies squeeze beef business

TSN•2026-08-03